(8R,9S)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazin-3-one
CAS: 1207456-00-5
Ref. 3D-FF103523
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado |
Informação sobre produto
Nome:
(8R,9S)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazin-3-one
Descrição:
Talazoparib is a potent DNA methyltransferase inhibitor that has been shown to inhibit the activity of breast and ovarian cancer cells. It does not have any cytotoxic effects on normal cells, which makes it a promising drug for cancer treatment. Talazoparib inhibits the enzyme DNA methyltransferase, preventing the transfer of methyl groups to dna and rna. This inhibition prevents cell proliferation and induces apoptosis in cancer cells. Talazoparib is currently being developed as a potential anticancer drug for platinum-resistant ovarian cancer.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
380.35 g/mol
Fórmula:
C19H14F2N6O
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
